Wound Care (Pharmacies) - Southeast Asia

Southeast Asia

Highlights

Revenue in the Wound Care market is projected to reach US$74.12m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.76%, resulting in a market volume of US$76.98m by 2029.
In global comparison, most revenue will be generated United States (US$1.04bn in 2024).
In relation to total population figures, per person revenues of US$0.11 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Wound Care (Pharmacies) market in Southeast Asia is experiencing significant growth and development due to various factors. Customer preferences in the region are driving the demand for wound care products in pharmacies. Consumers are becoming more health-conscious and are seeking convenient and accessible solutions for their healthcare needs. Pharmacies offer a wide range of wound care products that cater to different types of wounds, such as cuts, scrapes, and burns. Customers prefer to purchase these products from pharmacies because of the convenience they offer, as pharmacies are easily accessible and provide professional advice from pharmacists. One of the trends in the market is the increasing demand for advanced wound care products. As the healthcare infrastructure in Southeast Asia continues to improve, there is a growing awareness and acceptance of advanced wound care products. These products, such as hydrogels, foam dressings, and negative pressure wound therapy, provide better wound healing outcomes compared to traditional wound care methods. The demand for these advanced products is driven by the desire for faster healing, reduced pain, and improved quality of life. Another trend in the market is the rising popularity of natural and organic wound care products. Consumers in Southeast Asia are becoming more conscious of the ingredients used in the products they use, including wound care products. They are seeking products that are free from harmful chemicals and are made from natural or organic ingredients. This trend is driven by the increasing awareness of the potential side effects of synthetic ingredients and the desire for more sustainable and environmentally friendly options. Local special circumstances in each country also contribute to the development of the Wound Care (Pharmacies) market in Southeast Asia. For example, in countries with a large aging population, such as Singapore and Thailand, there is a higher demand for wound care products due to the increased prevalence of chronic wounds. Additionally, the tropical climate in the region can lead to more frequent and severe wounds, further driving the demand for wound care products. Underlying macroeconomic factors also play a role in the development of the market. The growing middle class in Southeast Asia has increased disposable incomes, allowing consumers to spend more on healthcare products, including wound care. Additionally, the increasing prevalence of chronic diseases, such as diabetes, in the region has led to a higher demand for wound care products to manage and treat related wounds. In conclusion, the Wound Care (Pharmacies) market in Southeast Asia is developing due to customer preferences for convenient and accessible healthcare solutions, the increasing demand for advanced and natural wound care products, local special circumstances, and underlying macroeconomic factors. As the region continues to experience economic growth and improvements in healthcare infrastructure, the market is expected to further expand in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.